GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
IsoRay Inc. (ISR) [hlAlert]

IsoRay, Inc. is engaged in the development of permanent seed brachytherapy in the treatment of cancers. IsoRay, Inc. has obtained clearance from the United States Food and Drug Administration (FDA) for treatment for all solid tumor applications using Cesium-131 (Cs-131). Such applications include prostate
cancer; ocular melanoma; head, neck and lung tumors; and breast, liver, brain and pancreatic cancer. The seed may be used in surface, interstital and intracavity applications for tumors with known radio sensitivity. On June 1, 2009, the Company expanded its application of Cs-131 with the treatment of a head and neck tumor that could not be accessed by other treatment modalities. IsoRay International LLC (International) is a wholly owned subsidiary of the Company. During fiscal year ended June 30, 2009, the Company divested its ownership in the Russian LLC.
.
( Total: 4 Current Stock Recommendations )
IsoRay Inc.   (4)
Hold 25% Buy 75%
Related companies
Biosphere Medical, ...   (2)
Buy 100%
TearLab Corporation   (3)
Buy 100%
INTELLIPHARMACEUTICS ...   (3)
Buy 100%
Stereotaxis, Inc.   (7)
Buy 100%
Iridex Corporation   (1)
Buy 100%
Photomedex, Inc.   (8)
Buy 100%
Antares Pharma, Inc.   (8)
Buy 100%
Icad Inc.   (4)
Buy 100%
Zoll Medical ...   (7)
Buy 100%
Lemaitre Vascular, ...   (5)
Buy 100%
Show  

Date (ET)MemberRatingYTD
Gains
 
2/13/2008  
Buy
up  456.00 %
3/17/2010  
Buy
up  456.00 %
11/1/2013  
Buy
up  456.00 %
8/21/2008  
Hold
  

* As of 7/18/2014 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy